Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution

M D Planas-Silva1, R A Weinberg

  • 1Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.

Molecular and Cellular Biology
|July 1, 1997
PubMed
Summary

Estrogen and antiestrogen treatments affect breast cancer cell growth by altering cell cycle progression. Estradiol activates specific cyclin-dependent kinases, promoting proliferation in MCF-7 cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells.

Oncogene·2015
Same author

Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells.

Oncogene·2014
Same author

Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence.

Oncogene·2010
Same author

The evolving portrait of cancer metastasis.

Cold Spring Harbor symposia on quantitative biology·2006
Same author

Derivation of human tumor cells in vitro without widespread genomic instability.

Cancer research·2001
Same author

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

Cell·2001

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Cancer Research

Background:

  • Estrogens and antiestrogens are critical regulators of breast cancer cell growth.
  • Understanding their mechanisms involves analyzing cell cycle dynamics.
  • MCF-7 human mammary carcinoma cells are a relevant model for studying these effects.

Purpose of the Study:

  • To elucidate the mechanisms of estrogen and antiestrogen action on breast cancer cell proliferation.
  • To characterize cell cycle changes induced by estradiol during the G1 phase in MCF-7 cells.

Main Methods:

  • Characterization of cell cycle phase transitions in MCF-7 cells.
  • Analysis of cyclin and cyclin-dependent kinase (CDK) activities.
  • Assessment of CDK inhibitor (p21, p27) associations with CDK complexes.

Related Experiment Videos

Main Results:

  • Estradiol treatment relieved tamoxifen-induced cell cycle arrest.
  • Activation of cyclin E-CDK2 complexes and retinoblastoma protein phosphorylation occurred within 6 hours.
  • Cyclin D1 levels increased, while cyclin E, CDK2, p21, and p27 levels remained stable; p21 shifted from cyclin E-CDK2 to cyclin D1-CDK4.

Conclusions:

  • Cyclin D1 plays a significant role in steroid-dependent breast cancer cell proliferation.
  • Estrogen regulates G1 cyclin-dependent kinase activity to control breast cancer cell proliferation.
  • These findings provide insights into targeted therapies for hormone-responsive breast cancers.